These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 36852477)

  • 1. Determination and quantification of related substances and degradation products in bictegravir by full factorial design evaluated HPLC and mass spectrometry.
    Kumar SRJ; Rao VK; Katari NK; Jyothi NS; Kowtharapu LP
    Anal Methods; 2023 Mar; 15(10):1274-1285. PubMed ID: 36852477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of RP UPLC-TOF/MS, stability indicating method for omeprazole and its related substances by applying two level factorial design; and identification and synthesis of non-pharmacopoeial impurities.
    Jadhav SB; Kumar CK; Bandichhor R; Bhosale PN
    J Pharm Biomed Anal; 2016 Jan; 118():370-379. PubMed ID: 26600119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a novel HPLC method for the determination of the impurities in desonide cream and characterization of its impurities by 2D LC-IT-TOF MS.
    Wang J; Zheng S; Xu Y; Hu H; Shen M; Tang L
    J Pharm Biomed Anal; 2018 Nov; 161():399-406. PubMed ID: 30205304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Identification of impurity peaks in the HPLC chromatogram by LC-MS and two-dimensional chromatographic correlation spectroscopy].
    Chen ZZ; Zhang DS; Wang N; Feng F; Hu CQ
    Yao Xue Xue Bao; 2012 Apr; 47(4):492-7. PubMed ID: 22799032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Forced degradation and impurity profiling: recent trends in analytical perspectives.
    Jain D; Basniwal PK
    J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of Five Oxidative Degradation Impurities and One Process Impurity of Suvorexant Drug Substance by LC-MS/MS, HR-MS and 1D, 2D NMR: Validation of Suvorexant Drug Substance and Process Impurities by HPLC and UPLC.
    Rajana N; Devi DR; Kumar Reddy DN; Babu JM; Basavaiah K; Balakumaran K
    J Chromatogr Sci; 2020 Apr; 58(5):433-444. PubMed ID: 32134104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of a novel stability-indicating HPLC method for the quantitative determination of eleven related substances in ezetimibe drug substance and drug product.
    Luo Z; Deng Z; Liu Y; Wang G; Yang W; Hou C; Tang M; Yang R; Zhou H
    Talanta; 2015 Jul; 139():67-74. PubMed ID: 25882410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impurity Profile of Bronchodilators used in Asthma: A Critical Review.
    Prajapati KJ; Kothari CS
    Curr Drug Discov Technol; 2018; 15(4):272-304. PubMed ID: 28875855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Active drug substance impurity profiling part II. LC/MS/MS fingerprinting.
    Nicolas EC; Scholz TH
    J Pharm Biomed Anal; 1998 Jan; 16(5):825-36. PubMed ID: 9535195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation, structure characterization and quantification of related impurities in asperosaponin VI.
    Ji D; Liu YF; Wang QH; Zhang CF; Yang ZL
    Chin J Nat Med; 2013 Jul; 11(4):419-26. PubMed ID: 23845554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous quantification of (E) and (Z) isomers of rilpivirine and four degradation products in bulk and tablets by reversed-phase ultra-high-performance liquid chromatography and confirmation of all by molecular weight.
    Mhaske DK; Kumbhar AS
    J Sep Sci; 2023 Jul; 46(13):e2201067. PubMed ID: 37021513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Degradation pathways and impurity profiling of the anticancer drug apalutamide by HPLC and LC-MS/MS and separation of impurities using Design of Experiments.
    Lakka NS; Kuppan C; Vadagam N; Reddamoni SY; Muthusamy C
    Biomed Chromatogr; 2023 Feb; 37(2):e5549. PubMed ID: 36409057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the polymerized impurities in cefmetazole sodium based on novel separation principle by liquid chromatography tandem ion trap/time-of-flight mass spectrometry.
    Wang F; Ren X; Zhu B; Zhang F; Gao J; Hong L; Wang J
    J Pharm Biomed Anal; 2022 Jun; 215():114790. PubMed ID: 35483231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A high pH based reversed-phase high performance liquid chromatographic method for the analysis of aminoglycoside plazomicin and its impurities.
    Tan L; Wlasichuk KB; Schmidt DE; Campbell RL; Hirtzer P; Cheng L; Karr DE
    J Pharm Biomed Anal; 2012 Jul; 66():75-84. PubMed ID: 22459505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a method of analysis for profiling of the impurities in phenoxymethylpenicillin potassium based on the analytical quality by design concept combined with the degradation mechanism of penicillins.
    Du J; Chang Y; Zhang X; Hu C
    J Pharm Biomed Anal; 2020 Jul; 186():113309. PubMed ID: 32380353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical practical aspects in the application of liquid chromatography-mass spectrometric studies for the characterization of impurities and degradation products.
    Narayanam M; Handa T; Sharma P; Jhajra S; Muthe PK; Dappili PK; Shah RP; Singh S
    J Pharm Biomed Anal; 2014 Jan; 87():191-217. PubMed ID: 23706957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural Elucidation of Novel Degradation Impurity and Development, Validation of a Single HPLC Method for all Putative Impurities of Clobetasol Propionate in a Foam Drug Product.
    Ketha NVDP; Kolli D; Subbappa PK
    J Chromatogr Sci; 2024 May; 62(5):444-453. PubMed ID: 36857571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of novel RP-HPLC method for midostaurin determination using analytical quality by design approach from regulatory perspective and determination of major degradation compounds of midostaurin using LC-MS.
    Reddy Saddala MP; Konduru N; Gundla R; Kowtharapu LP
    Biomed Chromatogr; 2022 Dec; 36(12):e5486. PubMed ID: 36001450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation and Characterization of an Unknown Process-Related Impurity in Furosemide and Validation of a New HPLC Method.
    Xu A; Xue Y; Zeng Y; Li J; Zhou H; Wang Z; Chen Y; Chen H; Jin J; Zhuang T
    Molecules; 2023 Mar; 28(5):. PubMed ID: 36903659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of a selective, sensitive and stability indicating UPLC-MS/MS method for rapid, simultaneous determination of six process related impurities in darunavir drug substance.
    A VBR; Yusop Z; Jaafar J; Aris AB; Majid ZA; Umar K; Talib J
    J Pharm Biomed Anal; 2016 Sep; 128():141-148. PubMed ID: 27262107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.